Posted 17th January 2020 by Joshua Sewell
Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.
Posted 14th January 2020 by Joshua Sewell
Plant growth-promoting bacteria (PGPB) have been identified as potential biofertilizers, eco-friendly, renewable and have been demonstrated to actively restore soil fertility. Beyond this, they have been shown to be a promising biological resource to augment chemical fertilizer, and drastically reduce its application and subsequent negative effects.
Posted 10th January 2020 by Liv Sewell
Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.
Posted 8th January 2020 by Joshua Sewell
Understandably, one of the main themes of the recent Plant Genomics & Gene Editing Congress: USA was how research and industry can enable farmers and plant growers to meet the growing challenges of global food security. In his presentation, Greg Bryan introduced us to ZeaKal, a photosynthesis company developing solutions for farmers.
Posted 6th January 2020 by Joshua Sewell
Alongside the talks at our conferences, the poster presentations are a huge part of the knowledge sharing that takes place. We’re thrilled to be able to take a closer look at this poster from the Research & Technology Series, presented by Wim van Esch and the team at Sanquin.
Posted 3rd January 2020 by Joshua Sewell
On June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.
Posted 30th December 2019 by Liv Sewell
Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…
Posted 20th December 2019 by Joshua Sewell
Kellye Eversole told us that “a major paradigm shift in agricultural production is required to meet the demands of a global world population projected to reach 9.7 billion in 2050. We have to increase crop productivity sustainably while preserving biodiversity, natural resources, and grower income in the context of climate change.”